COVID-19 Toolkit for liver patient associations
This toolkit provides offers step-by-step advice on:
- helping patient associations to communicate accurate information about COVID-19 to patients
- advising on the use of social media and newsletters to make communication with patients easier
- tips on how advocacy can be used to improve the situation and treatment of liver disease patients
This toolkit was published together with the accompanying lay summary, Care of Patients with Rare Liver Diseases during the Covid-19 Pandemic. They were written as a collaboration among patient organisations, advisory groups, and EASL board members, and are based on the “ESCMID-EASL Position Paper”, originally published in the Journal of Hepatology.